CORTICOSTEROIDS AND MIFEPRISTONE
The UK manufacturer of mifepristone says that the efficacy of corticosteroids (including inhaled corticosteroids) is expected to be reduced in the 3 to 4 days following the use of mifepristone.
Patients taking corticosteroids should be monitored in the 3 to 4 days following the use of mifepristone, and consideration given to increasing the corticosteroid dose. The US manufacturer contraindicates the use of mifepristone in those receiving long-term corticosteroid therapy.
Patients taking corticosteroids should be monitored in the 3 to 4 days following the use of mifepristone, and consideration given to increasing the corticosteroid dose. The US manufacturer contraindicates the use of mifepristone in those receiving long-term corticosteroid therapy.